+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Carrier Screening Market Research Report: By Type, Application, Technology, End User - Global Industry Analysis and Growth Forecast to 2030

  • ID: 5128884
  • Report
  • May 2020
  • Region: Global
  • 160 pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • Gene By Gene Ltd.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • MedGenome Inc.
  • Mount Sinai Genomics Inc.
To check the high prevalence of genetic disorders, biotechnological companies are introducing a number of cost-effective and technologically advanced testing kits and products. For instance, in October 2019, Sema4 (Mount Sinai Genomics Inc.) expanded its carrier screen with personalized residual risk, to offer healthcare providers and patients a better assessment of the genetic disease risk.

As a result of the testing kits becoming more advanced and cost-effective, the global carrier screening market, which reached $1,303.6 million in 2019, is predicted to grow at a 10.9% CAGR between 2020 and 2030. This is because of the increasing efficiency and reducing costs of the tests, which is driving the demand for them, among people planning a family.

Expanded Carrier Screening To Be Larger Type in Carrier Screening Market

The expanded carrier screening bifurcation is projected to continue holding larger share in the carrier screening market till 2030. This is attributed to the fact that with this approach, a number of genetic diseases can be tested for at once. Another reason behind the dominance of this bifurcation on the industry is the heavy usage of the next-generation sequencing (NGS) technique for genetic disease screening.

In 2019, the deoxyribonucleic acid (DNA) sequencing division contributed the highest revenue to the carrier screening market, on account of the integration of user-friendly tools with the technology and its declining prices. Moreover, this technology is more accessible, as the people using it for testing do not need to be bioinformatics experts.

During the forecast period, the cystic fibrosis classification would witness the highest CAGR in the carrier screening market, due to the increasing number of people being diagnosed with this genetic condition in North America and Europe. In addition, the awareness about the advantages of diagnosing the disease early is rising, thereby driving the test volume.

North America was the highest-revenue-generating carrier screening market during the historical period (2014–2019), as a result of the growing number of tests being done to determine whether a person is carrying the gene for an inherited disease. Moreover, several established market players are present in the region, which also has the most advanced healthcare infrastructure in the world. In the coming years, the fastest market growth is expected in Asia-Pacific (APAC), as people in Australia, China, and India are becoming rapidly knowledgeable about genetic diseases and screening tests. Additionally, APAC is the most populated region on earth, and the prevalence of genetic diseases is rising here, particularly in China and India.

Market Players Entering into Partnerships to Increase their Presence

A number of partnerships are being initiated in the carrier screening market, with the companies, offering these solutions, looking to:
  • Leverage each other’s platforms for their products
  • Combine each other’s technology, to offer improved solutions
  • Commercialize their products outside their home country
  • Widen their customer base
  • Advance their technology with each other’s expertise
The most prominent companies operating in the global carrier screening market include Invitae Corporation, Illumina Inc., Thermo Fisher Scientific Inc., Otogenetics Corporation, Myriad Genetics Inc., Luminex Corporation, Gene By Gene Ltd., MedGenome Inc., Natera Inc., Laboratory Corporation of America Holdings, and Mount Sinai Genomics Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Gene By Gene Ltd.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • MedGenome Inc.
  • Mount Sinai Genomics Inc.
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by End User
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by Technology
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.1.1 By method
2.2.2 Breakdown of Primary Research Respondents
2.2.2.1 By region
2.2.2.2 By industry participant
2.2.2.3 By company type
2.2.3 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 KOLs’ Sources
2.6 Data Triangulation
2.7 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Expanded carrier screening
4.1.1.2 Targeted carrier screening
4.1.2 By End User
4.1.2.1 Hospitals
4.1.2.2 Laboratories
4.1.2.3 Clinics
4.1.2.4 Others
4.1.3 By Application
4.1.3.1 Cystic fibrosis
4.1.3.2 Thalassemia
4.1.3.3 SMA
4.1.3.4 SCD
4.1.3.5 Fragile X syndrome
4.1.3.6 Others
4.1.4 By Technology
4.1.4.1 DNA sequencing
4.1.4.2 PCR
4.1.4.3 Microarray
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Growing number of acquisitions
4.2.2 Drivers
4.2.2.1 Increasing case of genetic diseases
4.2.2.2 Growing affordability and availability
4.2.2.3 Increasing advanced product launches
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Technical challenges
4.2.3.2 Lack of interest and knowledge among general public
4.2.3.3 Impact analysis of restraints on market forecast
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast
5.1 By Type
5.2 By End User
5.3 By Application
5.4 By Technology
5.5 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Type
6.2 By End User
6.3 By Application
6.4 By Technology
6.5 By Country

Chapter 7. Europe Market Size and Forecast
7.1 By Type
7.2 By End User
7.3 By Application
7.4 By Technology
7.5 By Country

Chapter 8. APAC Market Size and Forecast
8.1 By Type
8.2 By End User
8.3 By Application
8.4 By Technology
8.5 By Country

Chapter 9. LATAM Market Size and Forecast
9.1 By Type
9.2 By End User
9.3 By Application
9.4 By Technology
9.5 By Country

Chapter 10. MEA Market Size and Forecast
10.1 By Type
10.2 By End User
10.3 By Application
10.4 By Technology
10.5 By Country

Chapter 11. Major Markets: Segment Analysis
11.1 U.S.
11.1.1 By Type
11.1.2 By Application
11.2 Canada
11.2.1 By Type
11.2.2 By Application
11.3 Germany
11.3.1 By Type
11.3.2 By Application
11.4 France
11.4.1 By Type
11.4.2 By Application
11.5 U.K.
11.5.1 By Type
11.5.2 By Application
11.6 Italy
11.6.1 By Type
11.6.2 By Application
11.7 Spain
11.7.1 By Type
11.7.2 By Application
11.8 China
11.8.1 By Type
11.8.2 By Application
11.9 Japan
11.9.1 By Type
11.9.2 By Application
11.10 India
11.10.1 By Type
11.10.2 By Application

Chapter 12. Competitive Landscape
12.1 List of Players and Their Offerings
12.2 Market Share Analysis of Key Players
12.3 Competitive Benchmarking of Key Players
12.4 Global Strategic Developments in the Market
12.4.1 Mergers, Acquisitions, and Investments
12.4.2 Product and Service Launches
12.4.3 Partnerships

Chapter 13. Company Profiles
13.1 Invitae Corporation
13.1.1 Business Overview
13.1.2 Product and Service Offerings
13.1.3 Key Financial Summary
13.2 Illumina Inc.
13.2.1 Business Overview
13.2.2 Product and Service Offerings
13.2.3 Key Financial Summary
13.3 Thermo Fisher Scientific Inc.
13.3.1 Business Overview
13.3.2 Product and Service Offerings
13.3.3 Key Financial Summary
13.4 Otogenetics Corporation
13.4.1 Business Overview
13.4.2 Product and Service Offerings
13.5 Myriad Genetics Inc.
13.5.1 Business Overview
13.5.2 Product and Service Offerings
13.5.3 Key Financial Summary
13.6 Luminex Corporation
13.6.1 Business Overview
13.6.2 Product and Service Offerings
13.6.3 Key Financial Summary
13.7 Gene By Gene Ltd.
13.7.1 Business Overview
13.7.2 Product and Service Offerings
13.8 MedGenome Inc.
13.8.1 Business Overview
13.8.2 Product and Service Offerings
13.9 Natera Inc.
13.9.1 Business Overview
13.9.2 Product and Service Offerings
13.9.3 Key Financial Summary
13.10 Laboratory Corporation of America Holdings
13.10.1 Business Overview
13.10.2 Product and Service Offerings
13.10.3 Key Financial Summary
13.11 Mount Sinai Genomics Inc.
13.11.1 Business Overview
13.11.2 Product and Service Offerings

Chapter 14. Appendix
14.1 Abbreviations
14.2 Sources and References
14.3 Related Reports

List of Tables

TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 5 GLOBAL CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 6 GLOBAL CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 7 GLOBAL CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 8 GLOBAL CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 9 GLOBAL CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 10 GLOBAL CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 11 GLOBAL CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 12 GLOBAL CARRIER SCREENING MARKET, BY REGION, $M (2014-2019)
TABLE 13 GLOBAL CARRIER SCREENING MARKET, BY REGION, $M (2019-2024)
TABLE 14 NORTH AMERICA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 15 NORTH AMERICA CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 16 NORTH AMERICA CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 17 NORTH AMERICA CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 18 NORTH AMERICA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 19 NORTH AMERICA CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 20 NORTH AMERICA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 21 NORTH AMERICA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 22 NORTH AMERICA CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 23 NORTH AMERICA CARRIER SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 24 EUROPE CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 25 EUROPE CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 26 EUROPE CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 27 EUROPE CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 28 EUROPE CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 29 EUROPE CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 30 EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 31 EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 32 EUROPE CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 33 EUROPE CARRIER SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 34 APAC CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 35 APAC CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 36 APAC CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 37 APAC CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 38 APAC CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 39 APAC CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 40 APAC CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 41 APAC CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 42 APAC CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 43 APAC CARRIER SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 44 LATAM CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 45 LATAM CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 46 LATAM CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 47 LATAM CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 48 LATAM CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 49 LATAM CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 50 LATAM CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 51 LATAM CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 52 LATAM CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 53 LATAM CARRIER SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 54 MEA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 55 MEA CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 56 MEA CARRIER SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 57 MEA CARRIER SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 58 MEA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 59 MEA CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 60 MEA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 61 MEA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 62 MEA CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 63 MEA CARRIER SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 64 U.S. CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 65 U.S. CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 66 U.S. CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 67 U.S. CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 68 CANADA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 69 CANADA CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 70 CANADA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 71 CANADA CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 72 GERMANY CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 73 GERMANY CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 74 GERMANY CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 75 GERMANY CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 76 FRANCE CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 77 FRANCE CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 78 FRANCE CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 79 FRANCE CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 80 U.K. CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 81 U.K. CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 82 U.K. CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 83 U.K. CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 84 ITALY CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 85 ITALY CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 86 ITALY CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 87 ITALY CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 88 SPAIN CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 89 SPAIN CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 90 SPAIN CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 91 SPAIN CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 92 CHINA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 93 CHINA CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 94 CHINA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 95 CHINA CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 96 JAPAN CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 97 JAPAN CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 98 JAPAN CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 99 JAPAN CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 100 INDIA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2019)
TABLE 101 INDIA CARRIER SCREENING MARKET, BY TYPE, $M (2020-2030)
TABLE 102 INDIA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2019)
TABLE 103 INDIA CARRIER SCREENING MARKET, BY APPLICATION, $M (2020-2030)
TABLE 104 LIST OF PLAYERS AND THEIR OFFERINGS
TABLE 105 COMPETITIVE BENCHMARKING OF KEY PLAYERS (2019)
TABLE 106 INVITAE CORPORATION - AT A GLANCE
TABLE 107 INVITAE CORPORATION - KEY FINANCIAL SUMMARY
TABLE 108 ILLUMINA INC. - AT A GLANCE
TABLE 109 ILLUMINA INC. - KEY FINANCIAL SUMMARY
TABLE 110 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
TABLE 111 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
TABLE 112 OTOGENETICS CORPORATION - AT A GLANCE
TABLE 113 MYRIAD GENETICS INC. - AT A GLANCE
TABLE 114 MYRIAD GENETICS INC. - KEY FINANCIAL SUMMARY
TABLE 115 LUMINEX CORPORATION - AT A GLANCE
TABLE 116 LUMINEX CORPORATION - KEY FINANCIAL SUMMARY
TABLE 117 GENE BY GENE LTD. - AT A GLANCE
TABLE 118 MEDGENOME INC. - AT A GLANCE
TABLE 119 NATERA INC. - AT A GLANCE
TABLE 120 NATERA INC. - KEY FINANCIAL SUMMARY
TABLE 121 LABORATORY CORPORATION OF AMERICA HOLDINGS - AT A GLANCE
TABLE 122 LABORATORY CORPORATION OF AMERICA HOLDINGS - KEY FINANCIAL SUMMARY
TABLE 123 MOUNT SINAI GENOMICS INC. - AT A GLANCE

List of Figures

FIG 1 RESEARCH SCOPE
FIG 2 BREAKDOWN OF PRIMARY RESEARCH BY METHOD
FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY AND DESIGNATION
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL CARRIER SCREENING MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 15 GLOBAL CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 16 GLOBAL CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 17 GLOBAL CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 18 GLOBAL CARRIER SCREENING MARKET, BY REGION, $M (2014-2030)
FIG 19 NORTH AMERICA CARRIER SCREENING MARKET SNAPSHOT
FIG 20 NORTH AMERICA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 21 NORTH AMERICA CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 22 NORTH AMERICA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 23 NORTH AMERICA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 24 NORTH AMERICA CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2030)
FIG 25 EUROPE CARRIER SCREENING MARKET SNAPSHOT
FIG 26 EUROPE CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 27 EUROPE CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 28 EUROPE CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 29 EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 30 EUROPE CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2030)
FIG 31 APAC CARRIER SCREENING MARKET SNAPSHOT
FIG 32 APAC CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 33 APAC CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 34 APAC CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 35 APAC CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 36 APAC CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2030)
FIG 37 LATAM CARRIER SCREENING MARKET SNAPSHOT
FIG 38 LATAM CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 39 LATAM CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 40 LATAM CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 41 LATAM CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 42 LATAM CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2030)
FIG 43 MEA CARRIER SCREENING MARKET SNAPSHOT
FIG 44 MEA CARRIER SCREENING MARKET, BY TYPE, $M (2014-2030)
FIG 45 MEA CARRIER SCREENING MARKET, BY END USER, $M (2014-2030)
FIG 46 MEA CARRIER SCREENING MARKET, BY APPLICATION, $M (2014-2030)
FIG 47 MEA CARRIER SCREENING MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 48 MEA CARRIER SCREENING MARKET, BY COUNTRY, $M (2014-2030)
FIG 49 GLOBAL CARRIER SCREENING MARKET SHARE OF KEY PLAYERS (2019)
FIG 50 INVITAE CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 51 ILLUMINA INC. - REVENUE SPLIT BY PRODUCTS AND SERVICES AND GEOGRAPHY (2019)
FIG 52 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 53 MYRIAD GENETICS INC. - REVENUE SPLIT BY SEGMENT (2019)
FIG 54 LUMINEX CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 55 NATERA INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 56 LABORATORY CORPORATION OF AMERICA HOLDINGS - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
  • Invitae Corporation
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Otogenetics Corporation
  • Myriad Genetics Inc.
  • Luminex Corporation
  • Gene By Gene Ltd.
  • MedGenome Inc.
  • Natera Inc.
  • Laboratory Corporation of America Holdings
  • Mount Sinai Genomics Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll